Cancer research firm CG Oncology Inc., which has a novel treatment that’s been called a “game changer” for bladder cancer, is aiming for a $1 billion valuation when it goes public in the coming days.

Five months after reeling in $105 million from a pre-IPO crossover round, CG Oncology is now ready to take the plunge and go public. The company has yet to reveal an estimate for how much the shares ...

(RTTNews) - CG Oncology Inc. (CGON), a clinical-stage biopharmaceutical company, is making steady progress in the development of its lead investigational oncolytic immunotherapy, Cretostimogene, as ...

CG Oncology’s late-stage bladder cancer treatment notched a complete response in roughly three-quarters of treated patients, fueling optimism that the company’s Wall Street success story is no fluke.

Chaudhary Group (CG), the business house that has 137-year history, is slowly changing its gear and entering into the service sector. However, its involvement in the manufacturing sector will continue ...

Avantha Group company CG Power and Industrial Solutions Ltd is considering to offload its non-core assets and an equity fund raise to bridge the cash flow gaps and meet working capital requirements.